NTRA logo

Natera Inc (NTRA)

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal...

NASDAQHealthcareDiagnostics & ResearchUSA

公司簡介

股票程式碼
NTRA
ISIN程式碼
US6323071042
貨幣
US Dollar (USD)
IPO日期
2015-07-02

聯絡資訊

公司地址
13011 McCallen Pass, Austin, TX, United States, 78753
聯絡電話
650 980 9190
公司網站
https://www.natera.com
財年結束
December

財務亮點

市值
$999,999.99
毛利潤(TTM)
$999,999.99
資產回報率(TTM)
-8.08%
EBITDA
$-999,999.99
收入(TTM)
$999,999.99